In O
human O
proliferative O
cells O
, O
the O
NADP O
- O
dependent O
ME B
activity O
is O
poorly O
expressed O
and O
barely O
inducible O
by O
thyroid O
hormones O
. O

3 O
' O
RNA O
boundary O
experiments O
indicate O
that O
the O
5 O
' O
structure O
reduces O
the O
number O
of O
( O
G O
/ O
U O
) O
AG O
repeats O
required O
for O
stable O
TRAP B
- O
trp B
leader O
RNA O
association O
. O

These O
exons O
, O
further O
identified O
as O
exons O
9 O
, O
10 O
, O
and O
11 O
, O
together O
encode O
the O
37 O
amino O
acid O
residues O
present O
in O
alpha B
s1 I
- I
casein I
variant I
A I
but O
missing O
in O
variant O
F O
. O

Intron O
- O
exon O
structure O
of O
the O
porcine B
I I
kappa I
B I
alpha I
- I
encoding I
gene I
. O

We O
propose O
that O
two O
pathways O
regulate O
Stat5 B
serine O
phosphorylation O
, O
one O
that O
is O
prolactin B
- O
activated O
and O
PD98059 O
- O
resistant O
and O
one O
that O
is O
constitutively O
active O
and O
PD98059 O
- O
sensitive O
and O
preferentially O
targets O
Stat5a B
. O

Another O
mutant O
, O
T255A O
, O
lost O
the O
ability O
to O
bind O
E4orf6 B
, O
but O
unexpectedly O
, O
viral O
late O
- O
gene O
expression O
was O
not O
affected O
. O

Using O
this O
method O
, O
we O
were O
able O
to O
select O
strong O
enhancer O
- O
type O
activation O
domains O
from O
the O
immediate B
early I
regions I
of O
two O
herpesviruses O
, O
namely O
pseudorabies O
virus O
and O
bovine O
herpesvirus O
1 O
. O

Inhibition O
of O
the O
Raf B
- I
1 I
kinase I
by O
cyclic O
AMP O
agonists O
causes O
apoptosis O
of O
v B
- I
abl I
- O
transformed O
cells O
. O

Removal O
of O
beta B
2 I
- I
microglobulin I
by O
hemodialysis O
and O
hemofiltration O
: O
a O
four O
year O
follow O
up O
. O

They O
share O
many O
downstream O
targets O
, O
including O
remodeling O
of O
the O
actin B
cytoskeleton O
, O
activation O
of O
p70 B
( I
S6 I
) I
kinase I
and O
c B
- I
jun I
N I
- I
terminal I
kinase I
( O
JNK B
) O
, O
and O
regulation O
of O
transcription O
and O
cell O
proliferation O
. O

Excision O
repair O
at O
the O
level O
of O
the O
nucleotide O
in O
the O
Saccharomyces B
cerevisiae I
MFA2 I
gene I
: O
mapping O
of O
where O
enhanced O
repair O
in O
the O
transcribed O
strand O
begins O
or O
ends O
and O
identification O
of O
only O
a O
partial O
rad16 B
requisite O
for O
repairing O
upstream O
control O
sequences O
. O

20 O
% O
of O
total O
HSL B
transcripts I
in O
human O
subcutaneous O
adipocytes O
. O

Monitoring O
patients O
with O
acute O
leukemia O
for O
IL B
- I
1 I
and O
TNF B
levels O
throughout O
the O
clinical O
course O
of O
disease O
may O
help O
clarify O
the O
causes O
of O
febrile O
episodes O
. O

The O
inhibition O
of O
StAR B
gene I
transcription O
by O
DAX B
- I
1 I
was O
dose O
- O
dependent O
reducing O
transcription O
to O
6 O
% O
of O
control O
levels O
. O

Recurrence O
of O
bladder O
tumors O
among O
the O
original O
9 O
cases O
has O
occurred O
only O
among O
the O
5 O
whose O
properdin B
levels O
remained O
below O
the O
median O
. O

Here O
, O
we O
show O
that O
the O
phorbol O
ester O
PMA O
decreases O
both O
basal O
and O
dexamethasone O
/ O
cAMP O
- O
induced O
expression O
of O
a O
luciferase B
gene I
under O
the O
control O
of O
the O
G6Pase B
promoter I
in O
transiently O
transfected O
H4IIE O
hepatoma O
cells O
. O

This O
repressor O
is O
however O
unlikely O
to O
mediate O
spi B
2 I
. I
3 I
3 I
' I
UTR I
silencer I
action O
since O
it O
was O
not O
detected O
in O
rat O
hepatocytes O
. O

Molecular O
characterization O
of O
a O
large O
Borrelia O
burgdorferi O
motility O
operon O
which O
is O
initiated O
by O
a O
consensus O
sigma70 B
promoter I
. O

The O
IgA B
deficiency O
is O
combined O
with O
the O
IgE B
one O
. O

The O
tumor O
suppressor O
and O
transcriptional O
factor O
p53 B
is O
a O
phosphorylated O
protein O
. O

Recent O
studies O
have O
demonstrated O
that O
the O
activated O
GH B
receptor I
can O
stimulate O
Stat1 B
, O
a O
cytoplasmic O
transcription O
factor O
that O
becomes O
tyrosine O
phosphorylated O
and O
translocates O
to O
the O
nucleus O
, O
where O
it O
can O
interact O
with O
specific O
DNA O
sequences O
to O
modulate O
gene O
expression O
. O

Similar O
experiments O
with O
TR B
support O
the O
high O
affinity O
of O
RIP140 B
to O
the O
RXR B
subunit I
and O
also O
suggest O
that O
either O
partner O
in O
the O
TR B
/ O
RXR B
heterodimer O
can O
independently O
respond O
to O
ligand O
. O

Phase O
II O
trial O
of O
the O
anti B
- I
G I
( I
D2 I
) I
monoclonal I
antibody I
3F8 I
and O
granulocyte B
- I
macrophage I
colony I
- I
stimulating I
factor I
for O
neuroblastoma O
. O

In O
a O
stepwise O
logistic O
regression O
analysis O
of O
SPT O
and O
RAST O
data O
, O
the O
occurrence O
of O
serum B
IgE I
antibodies I
to I
P I
. I
orbiculare I
had O
the O
highest O
explanatory O
value O
for O
current O
eczema O
. O

The O
conserved O
ninth O
C O
- O
terminal O
heptad O
in O
thyroid O
hormone O
and O
retinoic B
acid I
receptors I
mediates O
diverse O
responses O
by O
affecting O
heterodimer O
but O
not O
homodimer O
formation O
. O

However O
, O
when O
directed O
to O
the O
nucleosome O
by O
fusion O
to O
core B
histone I
H2A I
or O
H2B B
, O
the O
non O
- O
histone B
tail O
forms O
an O
MCB O
that O
appears O
identical O
to O
that O
of O
the O
endogenous O
protein O
. O

Several O
cytokines O
exhibit O
a O
high O
degree O
of O
temporal O
regulation O
as O
well O
as O
somnogenic O
potency O
( O
e O
. O
g O
. O
, O
interleukin B
- I
1 I
[ O
IL B
- I
1 I
] O
, O
tumor B
necrosis I
factor I
- I
alpha I
[ O
TNF B
- I
alpha I
] O
) O
. O

